In Vitro Fertilization (IVF) Market Size, Share & Trends Analysis Report By Type (Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor), By End-User (Fertility Clinics, Hospitals), By Instrument (Culture Media, Disposable Devices, Capital Equipment) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

In Vitro Fertilization (IVF) Market Size

The global in vitro fertilization (IVF) market size was valued at USD 18.12 billion in 2023 and is projected to reach USD 31.16 billion by 2032, growing at a CAGR of 6.21% during the forecast period (2024–2032). Rising rates of infertility due to lifestyle changes, delayed childbearing, and medical conditions like polycystic ovary syndrome (PCOS) and endometriosis are significant drivers. The growing demand for assisted reproductive technologies (ART) to address these issues is fueling market growth.

In vitro fertilization (IVF) is a sophisticated assisted reproductive technology designed to help individuals and couples overcome infertility. The process starts with a thorough evaluation of reproductive health and the creation of a personalized treatment plan. Ovarian stimulation is used to encourage the development of multiple eggs, which are then monitored and retrieved via a minor surgical procedure. In the lab, eggs are fertilized with sperm through conventional methods or intracytoplasmic sperm injection (ICSI), and the resulting embryos are cultured and assessed for quality.

After that, the best embryos are selected for transfer into the uterus using a thin catheter. Post-transfer, medications may be prescribed to support implantation. A pregnancy test is conducted two weeks later to determine if the procedure was successful. IVF is utilized for various infertility issues, including blocked fallopian tubes and endometriosis, with success rates dependent on factors like age and embryo quality. The process requires a dedicated team of specialists to provide personalized, compassionate care.

Top 4 key highlights

• Fresh nondonor dominates the type segment.
• Fertility clinics dominate the end-user segment.
• Cultural media dominates the instrument segment.
• Europe is the highest shareholder in the global market

In Vitro Fertilization (IVF) Market Growth Factors

Rising reprotourism

Rising reprotourism is significantly boosting the global In Vitro Fertilization (IVF) market as patients increasingly travel abroad for more affordable and accessible fertility treatments. A 2020 study in Reproductive Biomedicine Online reveals that approximately 1.5 million cross-border reproductive care cycles occur annually. Popular destinations like Spain, the Czech Republic, and India offer IVF treatments at 30-70% lower costs compared to the U.S. or the UK. For instance, while an IVF cycle in the U.S. can cost $12,000-$15,000, in India, it is priced at $3,000-$5,000.

Several factors drive this trend. Firstly, long waiting lists in home countries contribute significantly; for example, NHS wait times in the UK can exceed two years, prompting many Britons to seek IVF abroad. Moreover, clinics in countries like Spain report higher success rates, with pregnancy rates of 55-60% compared to the global average of 40%, attracting patients seeking better outcomes.

Legal constraints also play a role, as restrictive IVF laws in over 50 countries drive patients to seek treatment where these procedures are permitted. For instance, Italy’s stringent regulations have led to a notable increase in Italians traveling to Spain for IVF since 2015. Moreover, the growing number of LGBTQ+ individuals seeking fertility treatments abroad—estimated at 7-10% of all reprotourists—further amplifies this trend. Rising reprotourism is reshaping the IVF landscape by making fertility care more accessible and tailored to diverse needs.

Market Restraining Factors

High cost of ivf treatment

The high cost of IVF treatment remains a major restraint in the global In Vitro Fertilization (IVF) market, limiting accessibility for many patients. In the U.S., the average IVF cycle costs USD 12,000 - 15,000, and with medications, the total can reach USD 20,000-25,000. Most patients require multiple cycles, with cumulative costs often exceeding USD 60,000. Limited insurance coverage exacerbates the issue; only 19 U.S. states mandate fertility treatment coverage, with many plans capping lifetime benefits at USD 25,000 - 30,000.

In the UK, while some NHS-funded cycles are available, 60% of IVF treatments in 2020 were privately funded at £3,000-£5,000 per cycle, highlighting regional disparities. Financial constraints disproportionately affect lower-income individuals; a 2018 study found that women earning less than USD 25,000 annually were 2.4 times less likely to pursue IVF compared to those earning over USD 100,000. Consequently, high costs and limited access constrain market growth, preventing 50-60% of infertile couples from obtaining treatment.

Market Opportunities

Technological advancement in ivf

Technological advancements are revolutionizing the global In Vitro Fertilization (IVF) market, creating exciting opportunities for growth. One of the most impactful innovations is Preimplantation Genetic Testing (PGT), which has surged in adoption from 12% of IVF cycles in 2014 to over 40% in 2022 in the U.S. PGT significantly boosts live birth rates by up to 30% by pinpointing the most viable embryos.

Another game-changer is time-lapse embryo monitoring systems, used in around 20% of IVF labs worldwide. These systems have enhanced embryo selection accuracy by 25%, elevating implantation rates from 45% to 56%. The advent of vitrification, a flash-freezing technique, has transformed egg and embryo preservation, improving survival rates from 60% with traditional slow-freezing to over 90%.

Intracytoplasmic Sperm Injection (ICSI), now utilized in about 70% of IVF cycles globally, has improved fertilization rates from 50% to over 80%, particularly benefiting those with severe male infertility. Moreover, AI and machine learning are pushing boundaries, with a 2019 study in NPJ Digital Medicine showing AI algorithms predicting embryo viability with 85% accuracy, compared to 60% by traditional methods. These technological strides are not only enhancing IVF success rates but also expanding the possibilities for patients, driving remarkable growth in the IVF market.

Regional Insights

North america dominates the global market

Europe stands as the dominant global market for In Vitro Fertilization (IVF), with a substantial share and strong growth prospects. In 2022, Europe accounted for 53% of global IVF cycles, according to the European Society of Human Reproduction and Embryology (ESHRE). This dominance is fueled by supportive government policies, advanced healthcare infrastructure, and a growing focus on reproductive health.

Countries like Spain, Germany, and the United Kingdom are leading the way. Spain, in particular, reported conducting over 160,000 IVF cycles in 2023, the highest number in Europe, as noted by the Spanish Fertility Society. These nations have implemented comprehensive regulations and reimbursement policies, making IVF treatments more accessible and affordable.

The region is home to state-of-the-art fertility clinics, with 37% of European clinics offering advanced techniques such as preimplantation genetic testing (PGT) in 2022 (ESHRE Clinic Data). The presence of over 28,000 fertility specialists across Europe in 2023, as reported by the European Board of Obstetrics and Gynecology, underscores the region’s expertise.

Additionally, the European Union's Horizon 2020 program has invested €7.5 billion in reproductive health research, driving innovation and technological advancements in IVF. This robust support system and infrastructure position Europe as a leading and expanding market in the global IVF industry.

Asia-pacific: fastest growing region with the highest cagr

The Asia-Pacific region is rapidly emerging as a significant player in the global In Vitro Fertilization (IVF) market, driven by rising infertility rates, evolving societal norms, and improved access to healthcare services. In 2022, the region accounted for 27% of global IVF cycles, according to the International Federation of Fertility Societies (IFFS). Countries like Japan, China, and India are leading this growth, with India alone seeing a 23% increase in IVF cycles between 2022 and 2023, as reported by the Indian Society for Assisted Reproduction.

The region’s expanding middle class and increasing disposable incomes have made IVF treatments more accessible and affordable. Governments are also playing a supportive role; for instance, Thailand and Malaysia began offering partial reimbursement for IVF procedures in 2023, as noted by their respective Ministries of Health.

Moreover, the region boasts several advanced fertility clinics. In 2022, 18% of Asia-Pacific clinics were equipped with state-of-the-art techniques such as cryopreservation and embryo banking, according to the Asia-Pacific Initiative on Reproduction. These advancements, combined with supportive policies and growing demand, position the Asia-Pacific region as a crucial and expanding market in the IVF sector.

In Vitro Fertilization (IVF) Market Segmentation Analysis

By type

The market is bifurcated into fresh nondonor, frozen nondonor, fresh donor, and frozen donor. Fresh non-donor IVF is the dominant type in the IVF market, accounting for the majority of cycles performed globally. This method uses the patient’s own eggs and sperm, which are fertilized in the lab and then transferred to the uterus. Its dominance stems from several key advantages: it boasts higher success rates, particularly for women under 35, and is widely available and accessible at most fertility clinics. Moreover, fresh non-donor IVF is often more cost effective and preferred by patients for its emotional benefits, as it involves using their genetic material. These factors make fresh non-donor IVF the most prevalent choice.

By end-users

The market is bifurcated into fertility clinics and hospitals. The fertility clinics segment leads the global IVF market, driven by a surge in demand for ART treatments. These clinics provide essential counseling and personalized IVF plans for couples struggling with infertility. As the number of fertility clinics and ART centers rises, they are expected to experience the highest growth rate in the coming years. To operate, these facilities must adhere to strict regulatory guidelines, which vary by region. Licensing requirements ensure that clinics meet local standards, further supporting their expansion and growth in the global market.

By instrument

The market is bifurcated into culture media, disposable devices, and capital equipment. The culture media segment leads the global IVF market, driven by rising government funding and organizational support for egg and sperm freezing. This support has significantly boosted demand for cryopreservation and culture media. Research and development efforts are focused on enhancing the efficiency of these media. Notably, Vitrolife's presentation at the American Society for Reproductive Medicine highlighted its SpermFreeze solution, which demonstrated similar effectiveness to traditional egg yolk-containing media in sperm recovery and binding while mitigating the risk of disease transfer from animal sources. Such advancements underline the growing need for innovative cryopreservation media.

Recent Development

• June 2024 - Senate Democrats introduced legislative protections for In Vitro Fertilization (IVF) patients. This move is expected to contribute to the growth by ensuring the safety and accessibility of IVF services, particularly for patients with insurance coverage issues. The legislation aims to protect patients' rights and improve access to fertility treatments.
• June 2024 - North Dakota residents can now access IVF treatments through a new clinic. This development is expected to contribute to the growth by increasing access to fertility services, particularly in rural areas. The clinic offers advanced IVF technologies and personalized care, enhancing patient outcomes and satisfaction.